Proffered paper session 2

13:00-14:00

Room: Hall 1C

THE REPORT OF THE BLOODWISE TAP CLARITY STUDY COMBINING IBRUTINIB AND VENETOCLAX IN RELAPSED, REFRACTORY CLL SHOWS ACCEPTABLE SAFETY AND PROMISING EARLY INDICATIONS OF EFFICACY
Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): EQ-5D, EORTC QLQ-C30 and LMC21 results from the FOXFIRE study
National Cancer Diagnosis Audit: initial results
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
Quality of Life (QOL) in patients undergoing combined therapy with TACE and Sorafenib – a sub-study of the TACE 2 Trial
A double blind, randomised trial of a natural nail bed balm profoundly reduces chemotherapy-induced onycholysis – The UK PolyBalm Study